Blog

Paralyzed Man Walks Again Using Brain-Wave System

A 26-year-old man who was paralyzed in both legs has regained the ability to walk using a system controlled by his brain waves, along with a harness to help support his body weight, a new study says. In order to walk, the patient wore a cap with electrodes that detected his brain signals. These electrical signals — the same as those…

Digging Deep: The Emotional Detox

We have all heard about detoxing… detoxing your physical body that is. You abstain from sugar, gluten, processed foods, meat, dairy and alcohol for a particular period of time, while possibly using an organic herbal product to aid in cleansing your system. To me, real detoxing takes more than a week or two. Actually, for some of us, depending…

Psychiatrists group warns DOJ insurance mergers could hurt care

The American Psychiatric Association warned U.S. antitrust regulators this month that two proposed health insurance deals could worsen access to mental health care services, adding to public opposition from several prominent doctor groups. Anthem Inc would become the largest U.S. health insurer through a proposed $47 billion acquisition of Cigna Corp, announced in late July. Earlier that month, Aetna Inc said it would buy the Humana Inc to make it

UK halts use of Silimed silicone implants amid contamination fears

By Kate Kelland LONDON (Reuters) – Sales of silicone implants made by Brazil’s Silimed and used in thousands of patients in Britain have been suspended due to safety concerns, British medical regulators and suppliers said on Thursday. The Medicines and Healthcare Products Regulatory Agency (MHRA) said it and other European regulators are testing Silimed’s products – which include breast, penile and testicular implants – after contamination was detected during an

EU regulator backs approval for GSK injectable asthma drug

(Reuters) – GlaxoSmithKline Plc said the European health regulator had recommended an approval for its injectable drug to treat asthma patients who don’t respond well to traditional inhalers. The European Commission is expected to decide on a final approval for the drug, Nucala, before the end of 2015. Nucala, a monthly injection, is also being tested for the treatment of chronic obstructive pulmonary disease, a respiratory disorder often associated with